East Delray, Florida
West Delray, Florida
The Boca Raton, Florida
Midtown Miami, Florida
Carillon Wellness Resort 
Midtown Tampa, Florida
Grand Wailea 
NOW OPEN 
TelehealthPeptides are everywhere. Safe access should be too.
Research-grade products moved quickly into the longevity market, often outside the traditional medical and pharmacy system. Now, the medical community and federal regulators are addressing the need for a safer, more responsible path to peptide care.
At the biostation, that physician-led model is already in place—and your evaluation can start today.
Educational information only. Treatment decisions require an individual
medical
evaluation.
Compounded medications are not FDA-approved.
Peptide interest moved fast.
The medical system had to catch up.
Interest Grew
Patients began seeking peptides for recovery, metabolic health, performance, and healthy aging.
Research-Grade Products Spread
Research-grade products became widely available without proper prescribing, sourcing, or clinical monitoring.
Longevity Experts Responded
Licensed providers and regulators held hearings, emphasizing appropriate evaluation, pharmacy standards, and patient safety.
What happened at the FDA peptide hearing?
On July 23 and 24, 2026, the FDA's Pharmacy Compounding Advisory Committee reviewed seven peptide-related bulk drug substances for potential inclusion on the Section 503A Bulk List.
Recommended for potential inclusion
Why this matters
Patients seeking these peptides are now required to be evaluated by licensed medical providers, prescribed, and sourced from a 503A FDA approved compounding pharmacy.
Access
Patients deserve informed access through a legitimate care pathway.
Quality
503A-licensed compounding pharmacies follow defined regulatory standards.
Clinical Oversight
Medical supervision helps guide dosing, follow-up, and monitoring.
Patient Safety
Licensed pharmacy sterility testing, potency, and trust what you are introducing to your body.
We have practiced patient-specific, physician-led peptide care for years.
Long before this hearing, our model centered on clinical evaluation, individual prescriptions, pharmacy coordination and ongoing care—not direct-to-consumer research products.
Licensed medical evaluation
Every patient begins with a provider review of health history, goals, medications and comprehensive bloodwork.
Individualized prescription
When prescribed, treatment is entered for an identified patient—not purchased as a general "research" product.
State-Licensed 503A pharmacy coordination
We coordinate prescriptions through licensed compounding pharmacies operating under applicable state and federal requirements.
Monitoring and follow-up
Progress, tolerability, labs when indicated, and care-plan changes are overseen by our medical team.
Your comprehensive wellness program includes:
After your consultation, you will receive a full recap and personalized plan of the recommendations that you discussed with your medical provider. This plan is referred to as your bID.
Schedule Your Peptide ConsultationIn the news
